Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.
对 RSL3 肿瘤抑制机制的重新表征表明,硒蛋白组是结直肠癌中可药物靶向的通路
期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-24-3478
DeAngelo Stephen L, Zhao Liang, Dziechciarz Sofia, Shin Myungsun, Solanki Sumeet, Balia Andrii, El-Derany Marwa O, Castillo Cristina, Qin Yao, Das Nupur K, Bell Hannah N, Paulo Joao A, Zhang Yuezhong, Rossiter Nicholas J, McCulla Elizabeth C, He Jianping, Talukder Indrani, Ng Billy Wai-Lung, Schafer Zachary T, Neamati Nouri, Mancias Joseph D, Koutmos Markos, Shah Yatrik M